Article
High ability to predict the treatment outcome of peginterferon and ribavirin combination therapy based on the reduction in HCV RNA levels at 4 weeks after starting therapy and amino acid substitutions in the hepatitis C virus in patients infected with HCV genotype 1b.
Journal of gastroenterology - 1 Apr 2011
Toyoda Hidenori, Kumada Takashi, Kiriyama Seiki, Tanikawa Makoto, Hisanaga Yasuhiro, Kanamori Akira, Tada Toshifumi, Arakawa Takahiro, Fujimori Masashi, Niinomi Takuro, Ando Naoto, Yasuda Satoshi, Sakai Keisuke, Kimura Jun
Abstract excerpt
BACKGROUND: The ability to predict the outcome of peginterferon (PEG-IFN) and ribavirin combination therapy based on the reduction in hepatitis C virus (HCV) RNA levels at 4 weeks after starting the therapy and amino acid substitutions in HCV was to be confirmed. METHODS: We measured the reductio...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.